Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4399-4406
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4399
Table 2 Univariate overall survival analysis of prognostic factors for patients with pancreatic cancer
Mean survival time (mo) (95%CI)Median survival time (mo) (95%CI)P value
Grading (G)
1-239.55 (32.36-46.74)24.00 (19.87-28.13)< 0.001
316.42 (12.86-19.98)14.00 (12.57-15.43)
Radicality
R035.88 (29.46-42.31)22.00 (18.36-25.64)0.004
R119.99 (12.62-27.38)13.00 (11.45-14.55)
Stage
I-II34.82 (28.47-41.18)21.00 (17.79-24.21)0.03
III-IV23.29 (14.70-31.87)14.00 (11.40-16.59)
Lymph nodes status
Neg43.29 (30.37-56.21)25.00 (17.055-32.95)0.04
Pos27.27 (22.52-32.02)18.00 (14.65-21.35)
Number of positive lymph nodes
< 326.62 (20.87-32.35)19.00 (13.09-24.90)0.74
> 328.39 (20.04-36.74)17.00 (12.93-21.07)
Lymph node ratio
≤ 0.1331.31 (23.69-38.93)20.00 (15.57-24.43)0.28
0.13-0.225.11 (13.23-36.99)14.00 (9.87-18.13)
> 0.223.29 (16.98-29.61)18.00 (14.57-21.43)
Para-aortic lymph nodes status
Neg42.06 (29.22-54.89)25.00 (17.17-32.83)0.02
Pos27.27 (22.54-32.02)18.00 (14.64-21.35)